The effect of anti-hypertensive therapy on urinary albumin excretion in Nigerian hypertensives. 1999

B L Salako, and S Kadiri, and F A Fehintola, and O O Akinkugbe
Department of Medicine, University of College Hospital, Ibadan, Oyo State, Nigeria.

The effect of blood pressure control on urinary protein excretion was assessed in 24 benign essential hypertensive subjects (12 males and 12 females). There were 23 controls (11 males and 12 females). Mean ages were 55 and 53 years respectively. Twenty-four hours urine was collected from each subject before and after control of blood pressure, while the controls had only one 24 h urine sample collected. 24 h urinary albumin excretion was assessed using the Bromocresol Green Method. Control of blood pressure in the subjects took an average of eight weeks. Subjects were either given hydroflumethiazide, alpha-methyldopa and/or prazosin as required. Blood pressure was measured in the right arm at each visit and pill counting was used to assess the compliance with therapy. The average urinary albumin excretion was significantly higher in the hypertensive subjects than the normotensive controls (P < 0.05). The average urinary albumin excretion after control of blood pressure was also significantly lower than, before control of blood pressure (P < 0.02). There was no correlation between SBP, DBP, MAP, and 24 h urinary albumin excretion in both subjects and controls. This study has shown that control of blood pressure can reduce or reverse urinary albumin excretion in Nigerian hypertensives.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D007202 Indicators and Reagents Substances used for the detection, identification, analysis, etc. of chemical, biological, or pathologic processes or conditions. Indicators are substances that change in physical appearance, e.g., color, at or approaching the endpoint of a chemical titration, e.g., on the passage between acidity and alkalinity. Reagents are substances used for the detection or determination of another substance by chemical or microscopical means, especially analysis. Types of reagents are precipitants, solvents, oxidizers, reducers, fluxes, and colorimetric reagents. (From Grant & Hackh's Chemical Dictionary, 5th ed, p301, p499) Indicator,Reagent,Reagents,Indicators,Reagents and Indicators
D008297 Male Males
D008750 Methyldopa An alpha-2 adrenergic agonist that has both central and peripheral nervous system effects. Its primary clinical use is as an antihypertensive agent. Methyldopate,alpha-Methyldopa,Aldomet,Alphamethyldopa,Apo-Methyldopa,Dopamet,Dopegit,Dopegyt,Dopergit,Hydopa,Meldopa,Nu-Medopa,Sembrina,alpha-Methyl-L-Dopa,Apo Methyldopa,Nu Medopa,alpha Methyl L Dopa,alpha Methyldopa
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009549 Nigeria A republic in western Africa, south of NIGER between BENIN and CAMEROON. Its capital is Abuja. Federal Republic of Nigeria
D011224 Prazosin A selective adrenergic alpha-1 antagonist used in the treatment of HEART FAILURE; HYPERTENSION; PHEOCHROMOCYTOMA; RAYNAUD DISEASE; PROSTATIC HYPERTROPHY; and URINARY RETENTION. Furazosin,Minipress,Pratsiol,Prazosin HCL,Prazosin Hydrochloride,HCL, Prazosin,Hydrochloride, Prazosin
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D001961 Bromcresol Green An indicator and reagent. It has been used in serum albumin determinations and as a pH indicator. Tetrabromocresolsulfonphthalein,Bromocresol Green,Green, Bromcresol,Green, Bromocresol
D003404 Creatinine Creatinine Sulfate Salt,Krebiozen,Salt, Creatinine Sulfate,Sulfate Salt, Creatinine

Related Publications

B L Salako, and S Kadiri, and F A Fehintola, and O O Akinkugbe
May 2012, International journal of cardiology,
B L Salako, and S Kadiri, and F A Fehintola, and O O Akinkugbe
December 1993, Blood pressure,
B L Salako, and S Kadiri, and F A Fehintola, and O O Akinkugbe
February 1997, Journal of human hypertension,
B L Salako, and S Kadiri, and F A Fehintola, and O O Akinkugbe
March 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation,
B L Salako, and S Kadiri, and F A Fehintola, and O O Akinkugbe
March 2011, Hypertension (Dallas, Tex. : 1979),
B L Salako, and S Kadiri, and F A Fehintola, and O O Akinkugbe
June 1960, Zeitschrift fur Kreislaufforschung,
B L Salako, and S Kadiri, and F A Fehintola, and O O Akinkugbe
June 1985, Endocrinologia japonica,
B L Salako, and S Kadiri, and F A Fehintola, and O O Akinkugbe
October 1992, Clinical science (London, England : 1979),
B L Salako, and S Kadiri, and F A Fehintola, and O O Akinkugbe
October 1992, Clinical science (London, England : 1979),
B L Salako, and S Kadiri, and F A Fehintola, and O O Akinkugbe
September 2003, Hypertension (Dallas, Tex. : 1979),
Copied contents to your clipboard!